110 related articles for article (PubMed ID: 24060153)
1. Proliferative lesions of intra-epidermal cytokeratin CAM5.2-positive cells in canine nipples.
Yasuno K; Nishiyama S; Kobayashi R; Yoshimura H; Takahashi K; Omachi T; Kamiie J; Shirota K
J Comp Pathol; 2014 Jan; 150(1):18-26. PubMed ID: 24060153
[TBL] [Abstract][Full Text] [Related]
2. Canine invasive lobular carcinoma of the mammary gland: morphological and immunohistochemical characterizations of three cases.
Ressel L; Millanta F; Poli A
J Comp Pathol; 2011 May; 144(4):303-7. PubMed ID: 20961557
[TBL] [Abstract][Full Text] [Related]
3. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
[TBL] [Abstract][Full Text] [Related]
4. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
5. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
6. Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers.
Kim NH; Lim HY; Im KS; Kim JH; Sur JH
J Comp Pathol; 2013 May; 148(4):298-306. PubMed ID: 23079102
[TBL] [Abstract][Full Text] [Related]
7. DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis.
Gärtner F; Geraldes M; Cassali G; Rema A; Schmitt F
Vet J; 1999 Jul; 158(1):39-47. PubMed ID: 10409415
[TBL] [Abstract][Full Text] [Related]
8. Histopathological and immunohistochemical characteristics of two canine lipid-rich mammary carcinomas.
Pérez-Martínez C; García-Iglesias MJ; Durán-Navarrete AJ; Espinosa-Alvarez J; García-Fernández RA; Lorenzana-Robles N; Fernández-Pérez S; García-Marín JF
J Vet Med A Physiol Pathol Clin Med; 2005 Mar; 52(2):61-6. PubMed ID: 15737173
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands.
Griffey SM; Madewell BR; Dairkee SH; Hunt JE; Naydan DK; Higgins RJ
Vet Pathol; 1993 Mar; 30(2):155-61. PubMed ID: 7682368
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
Amorim I; Lopes CC; Faustino AM; Pereira PD
J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
[TBL] [Abstract][Full Text] [Related]
11. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Faustino AM; van Garderen E; Schalken JA; Nederbragt H
J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
[TBL] [Abstract][Full Text] [Related]
12. The relationship between basal and luminal cytokeratins with histopathologic characteristics of canine mammary gland cancer.
Eivani D; Mortazavi P
Pol J Vet Sci; 2016; 19(2):261-9. PubMed ID: 27487499
[TBL] [Abstract][Full Text] [Related]
13. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
Ferreira E; Gobbi H; Saraiva BS; Cassali GD
Vet Pathol; 2012 Mar; 49(2):322-9. PubMed ID: 21282668
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous clear cell adnexal carcinoma in a dog: special reference to cytokeratin expression.
YASUNO K; NISHIYAMA S; SUETSUGU F; OGIHARA K; MADARAME H; SHIROTA K
J Vet Med Sci; 2009 Nov; 71(11):1513-7. PubMed ID: 19959904
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine carcinoma of the mammary gland in a dog.
Nakahira R; Michishita M; Yoshimura H; Hatakeyama H; Takahashi K
J Comp Pathol; 2015; 152(2-3):188-91. PubMed ID: 25670668
[TBL] [Abstract][Full Text] [Related]
16. Expression of 14-3-3 σ protein in normal and neoplastic canine mammary gland.
Suárez-Bonnet A; Herráez P; Martín de las Mulas J; Rodríguez F; Déniz JM; Espinosa de los Monteros A
Vet J; 2011 Dec; 190(3):345-51. PubMed ID: 21251859
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry with keratin, vimentin, desmin, and alpha-smooth muscle actin monoclonal antibodies in canine mammary gland: benign mammary tumours and duct ectasias.
Vos JH; van den Ingh TS; Misdorp W; Molenbeek RF; van Mil FN; Rutteman GR; Ivanyi D; Ramaekers FC
Vet Q; 1993 Sep; 15(3):89-95. PubMed ID: 7505510
[TBL] [Abstract][Full Text] [Related]
18. Expression of Ccdc85C, a causative protein for murine hydrocephalus, in the mammary gland tumors of dogs.
Tanaka N; Izawa T; Takenaka S; Akiyoshi H; Yamate J; Kuwamura M
Histol Histopathol; 2017 Apr; 32(4):397-403. PubMed ID: 27457231
[TBL] [Abstract][Full Text] [Related]
19. Atypical canine mammary adenoma characterized by cystic ducts comprising a single layer of basaloid cells with myoepithelial differentiation.
Yasuno K; Kobayashi R; Mineshige T; Sugahara G; Nagata M; Kamiie J; Shirota K
J Vet Med Sci; 2013; 75(8):1095-9. PubMed ID: 23546686
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
